--:--:--

Alembic Pharmaceuticals Limited

Web: alembic-india.com NSE: APLLTD BSE: 533573 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

788 2(0%)

Volume

1L as on 16, Oct

Open

1,032

High

1,056

Low

1,038

Close

790

VWAP

784

52 Week High

998

52 Week Low

636

Viand Research Rating
Quality Score

26/100

Growth Score

18/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

15,493

No. of Shares

19.7

P/E

27.36

P/B

4.22

Face Value

2

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

15.44

ROCE

-

Profit Growth

-

Listing Date

20-Sep-11

Rank/Sector Rank

#433/#42

Promoter Holding

69.74%

FII Holding

4.26%

DII Holding

16.17%

Price Chart
Price Performance
1 Week1%
1 Month4%
3 Months6%
6 Months5%
1 Year15%
YTD6%
Moving Average
5 Day SMA792
10 Day SMA806
20 Day SMA826
30 Day SMA822
50 Day SMA824
61 Day SMA821
80 Day SMA821
200 Day SMA780
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3813796808812
Resistance 2808795803807
Resistance 1800794800799
Pivot Point795793795794
Support 1787791790786
Support 2782790787781
Support 3774789782773
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 69.74%(0.01) 69.74%(0.11) 69.74%(0.01) 69.68%(0.11) 69.67%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.01) 69.61%(0.11) 69.61%(0.01) 69.48%(0.01) 69.48%
FIIs(0.01) 4.26%(0.21) 4.23%(0.11) 4.04%(0.01) 3.96%(-0.21) 3.94%(0.21) 4.17%(-0.41) 3.94%(-0.11) 4.32%(-0.11) 4.46%(0.01) 4.52%(0.21) 4.51%(-0.21) 4.34%(-0.41) 4.55%(-0.31) 4.99%(-0.61) 5.32%(-0.11) 5.94%(0.11) 6.02%(0.41) 5.89%(0.01) 5.52%
DIIs(0.01) 16.17%(-0.11) 16.17%(-0.21) 16.30%(0.01) 16.46%(0.41) 16.43%(0.01) 16.05%(0.61) 16.05%(0.11) 15.47%(0.91) 15.39%(0.31) 14.51%(0.61) 14.22%(0.31) 13.65%(0.61) 13.32%(0.21) 12.76%(0.41) 12.55%(0.41) 12.15%(0.11) 11.74%(0.21) 11.61%(0.01) 11.42%
Public9.83%9.84%9.92%9.91%9.96%10.17%10.38%10.61%10.54%11.36%11.67%12.39%12.53%12.64%12.52%12.30%12.63%13.03%13.58%
No. of Shareholders86,43287,00089,96989,01391,33693,94491,42974,82976,56785,21289,55297,60799,522101,864103,811101,457106,437110,038123,059
Quarterly Results
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
Sales18481876191017111770169316481562151716311595148614061509147512621416127212921326
Sales Growth % (YoY)4.4%10.8%15.9%9.5%16.7%3.8%3.3%5.1%7.9%8%8.1%17.8%-0.7%18.7%14.1%-4.8%10.6%-3.2%-11.3%-1.1%
Sales Growth % (QoQ)-1.5%-1.8%11.6%-3.3%4.5%2.7%5.5%3%-7%2.3%7.3%5.7%-6.8%2.3%16.9%-10.9%11.3%-1.5%-2.6%-
Expenses16201585159414301498143314091325125713641387128712031274124412551268103010541090
Operating Profit2282923162812712602392372602662081992042352317148242239236
OPM %121617161515151517161313141616110191818
Other Income2-2786141030243101210011019212
Interest23232424252219131115161414151297452
Depreciation89807674697071696969686674676867123565553
Profit before tax119162224190192178180157183185135130116154151-6729201200183
Tax %-701818191823151432-17-312112-224142019
Net Profit 202132184154157138153135178180137121153122133-6622172164158
Net Profit Growth % (QoQ)53%-28.3%19.5%-1.9%13.8%-9.8%13.3%-24.2%-1.1%31.4%13.2%-20.9%25.4%-8.3%301.5%-400%-87.2%4.9%3.8%-
Net Profit Growth % (YoY)28.7%-4.3%20.3%14.1%-11.8%-23.3%11.7%11.6%16.3%47.5%3%283.3%595.5%-29.1%-18.9%-141.8%----
TTM Net Profit6726276336025836046466306165915335293422112612925164943220
EPS in Rs10.316.769.47.857.987.047.86.859.079.186.956.147.766.26.78-3.351.128.748.348.37
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Sales73456672622956535306539346063935313131053166205618631520
Sales Growth %10.1%7.1%10.2%6.5%-1.6%17.1%17.1%25.7%0.8%-1.9%54%10.4%22.6%3.8%
Expenses62265664529649704432391333833061248824902159165315061268
Operating Profit11181008932682874148012238746436151007403358252
OPM %1515151216272722212032201917
Other Income-125628-25687-399727444
Interest947956501816271835541015
Depreciation3192792732752871831571151058372444035
Profit before tax69470763235562513681000749541529936359311206
Tax %3183417192021222323212420
Net Profit 6715826163425211146801583413403720283236165
Net Profit Growth %15.3%-5.5%80.1%-34.4%-54.5%43.1%37.4%41.2%2.5%-44%154.4%19.9%43%-
EPS in Rs34.3329.6831.3317.426.558.3343.973121.8921.3938.215.0112.498.77
Dividend Payout %353735463824231818199232429
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Cash from Operating Activity783888037245521463449812312329948172240265
Cash from Investing Activity-506-568-321-448-372-840-731-756-884-486-307-256-81-67
Cash from Financing Activity-164444-438-262-217-59715559503-129-22487-151-229
Net Cash Flow113-374514-3726-127115-69-28641738-31
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Equity Capital39393939393939393838383838383838
Reserves5636528051524849477943315198502831822681218218651560847638465
Borrowings14301489125810665137227175841747112870889114264109187
Other Liabilities1658158913241276111410901167105810229311013698718493432358
Total Liabilities8763839777737230644661837122670959894778394126892429164112171048
Fixed Assets3130283425242463254723981798178815521158993799708547397344
CWIP6349038376625246012304218318461551101039693832132
Investments14112912710293961182361849425087233
Other Assets48584531428540043281308729022502257320191896144415411009796668
Total Assets8763839777737230644661837122670959894778394126892429164112171048
Delivery

Delivery Data: APLLTD

#Date
771
14%
876
Value (Cr)Q/T
12
Del
47
Del
12
121-Oct788
5
5563
219-Oct790
11
10687
316-Oct789
12
13516
415-Oct793
6
7563
514-Oct792
6
11563
613-Oct798
6
12453
712-Oct789
9
10404
89-Oct801
15
14487
98-Oct800
14
12598
107-Oct834
11
8657
116-Oct834
12
7627
125-Oct831
23
76214
131-Oct815
27
126417
1430-Sep825
22
95111
1529-Sep862
39
144919
1628-Sep854
18
115810
1725-Sep864
26
96417
1824-Sep850
30
126921
1923-Sep844
12
11527
2022-Sep840
9
12484
2121-Sep849
21
15388
2218-Sep846
54
184424
2317-Sep826
33
18227
2416-Sep825
11
11485
2515-Sep825
14
11446
2611-Sep811
10
12414
2710-Sep816
10
10454
289-Sep817
7
10493
298-Sep808
16
166410
307-Sep800
14
13456
314-Sep808
14
13477
323-Sep804
13
14537
332-Sep827
15
14416
341-Sep844
10
9495
3531-Aug835
12
11647
3628-Aug813
7
17695
3727-Aug824
24
204410
3826-Aug825
4
11402
3925-Aug803
3
12522
4024-Aug817
3
10371
4121-Aug822
3
8552
4220-Aug814
4
8392
4319-Aug818
8
10635
4418-Aug825
4
7502
4517-Aug822
7
15725
4614-Aug831
7
5544
4713-Aug831
4
8552
4812-Aug842
12
16638
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct15,493c211c1.35
19-Oct15,704c176c1.13
17-Oct15,529c00
16-Oct15,529c12c0.08
15-Oct15,540c106c0.68
14-Oct15,646c59c0.38
13-Oct15,705c181c1.16
12-Oct15,525c198c1.26
09-Oct15,722c3c0.02
08-Oct15,725c614c3.76
05-Oct16,339c145c0.89
01-Oct16,195c320c1.94
29-Sep16,515c271c1.62
28-Sep16,787c240c1.45
25-Sep16,547c143c0.85
24-Sep16,689c178c1.08
22-Sep16,511c65c0.39
17-Sep16,576c216c1.32
10-Sep16,360c237c1.47
07-Sep16,123c355c2.25
04-Sep15,768c00
Stock Checklist
Price is above from 52 week high low average: 42%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 75 fund scheme(s) across 18 fund house(s) as of Oct26 · Total value ₹4,241 Cr · 36 increasing / 22 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
DSP Mutual Fund180.59%+0.02%916.6
Nippon India Mutual Fund30.31%+0.10%592.5
Aditya Birla Sun Life Mutual Fund20.29%+0.45%591.7
ICICI Prudential Mutual Fund81.15%+0.02%574.5
Kotak Mahindra Mutual Fund21.48%+0.03%565.9
UTI Mutual Fund100.77%+0.10%314.2
Union Mutual Fund22.56%-1.42%295.4
Axis Mutual Fund20.39%-240.3
Abakkus Mutual Fund21.41%-0.07%91.4
ICICI Prudential Asset Management Company Limited10.44%-43.4
The Wealth Company Mutual Fund40.74%+0.13%6.6
HDFC Mutual Fund40.20%-0.44%6.5
Groww Mutual Fund40.13%-0.06%1.1
Jio BlackRock Mutual Fund10.02%+0.02%0.7
Bandhan Mutual Fund40.11%+0.01%0.1
Motilal Oswal Mutual Fund40.00%-0
Mirae Asset Mutual Fund20.00%-0.02%0
Angel One Mutual Fund20.00%-0.02%0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0